Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00185796 · ClinicalTrials.gov registry record · Phase 2
TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD
A Phase 2 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 2
- Development phase
- 77
- Enrollment target
NCT00185796: Completed Phase 2 study, sponsored by Stanford University.
NCT00185796 is a Phase 2 study that has completed, run by Stanford University. The registered enrollment target is 77 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00185796, a Phase 2 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 77 participants
- Enrollment target
Study Summary
To evaluate the feasibility and safety of TLI/ATG conditioning for allogeneic HCT for elderly patients with advanced stage MDS and MPD.
Interventions
- PROCEDURE Total Lymphoid Irradiation (TLI)
- PROCEDURE Anti-Thymocyte Globulin as Conditioning (ATG)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2004-07 |
| Est. Completion | 2015-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00185796
The ClinicalTrials.gov registry entry for NCT00185796 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Total Lymphoid Irradiation (TLI) is the first listed.
NCT00185796 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00185796 about?
NCT00185796 is a clinical study titled "TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD". To evaluate the feasibility and safety of TLI/ATG conditioning for allogeneic HCT for elderly patients with advanced stage MDS and MPD.
What is the current status of trial NCT00185796?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 77 participants. The study started on 2004-07. Estimated completion is 2015-02.
What interventions are being tested in trial NCT00185796?
The interventions under investigation include: Total Lymphoid Irradiation (TLI) (PROCEDURE), Anti-Thymocyte Globulin as Conditioning (ATG) (PROCEDURE).
Who is sponsoring clinical trial NCT00185796?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.